Correlation Between Pieris Pharmaceuticals and ADC Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and ADC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and ADC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and ADC Therapeutics SA, you can compare the effects of market volatilities on Pieris Pharmaceuticals and ADC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of ADC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and ADC Therapeutics.
Diversification Opportunities for Pieris Pharmaceuticals and ADC Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pieris and ADC is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and ADC Therapeutics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADC Therapeutics and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with ADC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADC Therapeutics has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and ADC Therapeutics go up and down completely randomly.
Pair Corralation between Pieris Pharmaceuticals and ADC Therapeutics
Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to under-perform the ADC Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Pieris Pharmaceuticals is 1.12 times less risky than ADC Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The ADC Therapeutics SA is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 714.00 in ADC Therapeutics SA on February 3, 2024 and sell it today you would lose (241.00) from holding ADC Therapeutics SA or give up 33.75% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pieris Pharmaceuticals vs. ADC Therapeutics SA
Performance |
Timeline |
Pieris Pharmaceuticals |
ADC Therapeutics |
Pieris Pharmaceuticals and ADC Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pieris Pharmaceuticals and ADC Therapeutics
The main advantage of trading using opposite Pieris Pharmaceuticals and ADC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, ADC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADC Therapeutics will offset losses from the drop in ADC Therapeutics' long position.Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
ADC Therapeutics vs. Passage Bio | ADC Therapeutics vs. Black Diamond Therapeutics | ADC Therapeutics vs. Alector | ADC Therapeutics vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |